Cancer Medicines Forum

The European Medicines Agency (EMA) set up the Cancer Medicines Forum to help advance research into optimising cancer treatments and foster high standards in cancer care in the European Union (EU).
Human Medicines

EMA's Cancer Medicines Forum aims to help prioritise actions to fight cancer, in line with EMA's Regulatory Science Strategy to 2025 and academia collaboration matrix action plan.

EMA set up this forum in March 2022. 

It co-chairs the forum with the European Organisation for Research and Treatment of Cancer (EORTC).

Academia collaboration matrix action plan 2021-2023

Reference Number: EMA/159144/2021

English (EN) (224.02 kB - PDF)

First published:
Weergeven

For more information on cancer medicines, see:

Members

The forum brings together academic organisations from EMA’s Healthcare Professionals Working Party and the European medicines regulatory network. Other members include:

Observers include health technology assessment bodies, patient and industry organisations, and:

Meetings

The forum meets quarterly. 

Select the expandable panel below (via the arrow symbol) to access agendas, minutes and meeting materials:

Share this page

Back to top